Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11099467rdf:typepubmed:Citationlld:pubmed
pubmed-article:11099467lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11099467lifeskim:mentionsumls-concept:C0231337lld:lifeskim
pubmed-article:11099467lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:11099467lifeskim:mentionsumls-concept:C0007581lld:lifeskim
pubmed-article:11099467lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:11099467lifeskim:mentionsumls-concept:C0334094lld:lifeskim
pubmed-article:11099467lifeskim:mentionsumls-concept:C0030011lld:lifeskim
pubmed-article:11099467lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:11099467lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:11099467pubmed:issue15lld:pubmed
pubmed-article:11099467pubmed:dateCreated2001-2-5lld:pubmed
pubmed-article:11099467pubmed:abstractTextOxidized and cross-linked proteins tend to accumulate in aging cells. Declining activity of proteolytic enzymes, particularly the proteasome, has been proposed as a possible explanation for this phenomenon, and direct inhibition of the proteasome by oxidized and cross-linked proteins has been demonstrated in vitro. We have further examined this hypothesis during both proliferative senescence (this paper) and postmitotic senescence (see the accompanying paper, ref 1 ) of human BJ fibroblasts. During proliferative senescence, we found a marked decline in all proteasome activities (trypsin-like activity, chymotrypsin-like activity, and peptidyl-glutamyl-hydrolyzing activity) and in lysosomal cathepsin activity. Despite the loss of proteasome activity, there was no concomitant change in cellular levels of actual proteasome protein (immunoassays) or in the steady-state levels of mRNAs for essential proteasome subunits. The decline in proteasome activities and lysosomal cathepsin activities was accompanied by dramatic increases in the accumulation of oxidized and cross-linked proteins. Furthermore, as proliferation stage increased, cells exhibited a decreasing ability to degrade the oxidatively damaged proteins generated by an acute, experimentally applied oxidative stress. Thus, oxidized and cross-linked proteins accumulated rapidly in cells of higher proliferation stages. Our data are consistent with the hypothesis that proteasome is progressively inhibited by small accumulations of oxidized and cross-linked proteins during proliferative senescence until late proliferation stages, when so much proteasome activity has been lost that oxidized proteins accumulate at ever-increasing rates. Lysosomes attempt to deal with the accumulating oxidized and cross-linked proteins, but declining lysosomal cathepsin activity apparently limits their effectiveness. This hypothesis, which may explain the progressive intracellular accumulation of oxidized and cross-linked proteins in aging, is further explored during postmitotic senescence in the accompanying paper (1).lld:pubmed
pubmed-article:11099467pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099467pubmed:languageenglld:pubmed
pubmed-article:11099467pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099467pubmed:citationSubsetIMlld:pubmed
pubmed-article:11099467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11099467pubmed:statusMEDLINElld:pubmed
pubmed-article:11099467pubmed:monthDeclld:pubmed
pubmed-article:11099467pubmed:issn0892-6638lld:pubmed
pubmed-article:11099467pubmed:authorpubmed-author:GruntEElld:pubmed
pubmed-article:11099467pubmed:authorpubmed-author:DaviesK JKJlld:pubmed
pubmed-article:11099467pubmed:authorpubmed-author:MerkelMMlld:pubmed
pubmed-article:11099467pubmed:authorpubmed-author:Von...lld:pubmed
pubmed-article:11099467pubmed:authorpubmed-author:SitteNNlld:pubmed
pubmed-article:11099467pubmed:issnTypePrintlld:pubmed
pubmed-article:11099467pubmed:volume14lld:pubmed
pubmed-article:11099467pubmed:ownerNLMlld:pubmed
pubmed-article:11099467pubmed:authorsCompleteYlld:pubmed
pubmed-article:11099467pubmed:pagination2495-502lld:pubmed
pubmed-article:11099467pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:meshHeadingpubmed-meshheading:11099467...lld:pubmed
pubmed-article:11099467pubmed:year2000lld:pubmed
pubmed-article:11099467pubmed:articleTitleProtein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I--effects of proliferative senescence.lld:pubmed
pubmed-article:11099467pubmed:affiliationClinics of Physical Medicine and Rehabilitation, Humboldt University Berlin, Germany.lld:pubmed
pubmed-article:11099467pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11099467pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11099467pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11099467lld:pubmed